BriaCell Therapeutics Corp. (BCTX)
NASDAQ: BCTX · Real-Time Price · USD
0.7994
-0.0096 (-1.19%)
At close: Jul 25, 2025, 4:00 PM
0.8000
+0.0006 (0.08%)
After-hours: Jul 25, 2025, 7:41 PM EDT

BriaCell Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Aug - Jul.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202016 - 2020
Period Ending
Jul '25 Jul '24 Jul '23 Jul '22 Jul '21 Jul '20 2016 - 2020
514106101795
Upgrade
Market Cap Growth
-21.31%-87.19%4.90%29.07%1427.05%-50.55%
Upgrade
Enterprise Value
-8127757595
Upgrade
Last Close Price
0.8011.29100.3597.5076.20107.93
Upgrade
PB Ratio
0.45-5.08-28.189.822.84-1.43
Upgrade
P/TBV Ratio
0.44--10.052.87-
Upgrade
Debt / Equity Ratio
----0.00-0.11
Upgrade
Quick Ratio
3.410.2111.8043.64102.880.01
Upgrade
Current Ratio
3.410.4914.9645.00103.810.07
Upgrade
Return on Equity (ROE)
-688.17%--619.75%-141.25%-114.78%-
Upgrade
Return on Assets (ROA)
-131.54%-126.11%-41.71%-18.99%-14.89%-509.24%
Upgrade
Return on Capital (ROIC)
-534.73%--444.01%-50.26%-35.58%-
Upgrade
Earnings Yield
-363.88%-35.14%-19.08%-26.45%-17.58%-78.18%
Upgrade
FCF Yield
-459.29%-180.31%-22.31%-12.30%-9.86%-24.59%
Upgrade
Buyback Yield / Dilution
-119.48%-5.35%-0.81%-242.82%-533.09%-23.16%
Upgrade
Updated Mar 12, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q